Latest Clinical research Stories
-- Statistically Significant Data from Phase 2 Study Support Safety and Efficacy of Once Daily Dosing of NK-1 Antagonist, VPD-737 (serlopitant) SOUTH SAN FRANCISCO, Calif., Dec.
Three Patient Recruitment Veterans Now on One Team KENNESAW, Ga. and RALEIGH, N.C., Dec.
ROCKVILLE, Md., Dec. 17, 2014 /PRNewswire/ -- CASI Pharmaceuticals, Inc.
Over the past 11 years, thousands of device professionals have attended Medical Device Quality Congress (MDQC) and benefited from the unmatched educational sessions presented by FDA officials
Expands HITLAB's Clinical Trials Capabilities for Smart Biomedical Applications and Devices NEW YORK, Dec.
RnRMarketResearch.com adds "Lyme Disease Global Clinical Trials Review, H2, 2014" to its store.
New Cardiac Safety Methodology from iCardiac Technologies Offers Earlier Cardiac Safety Characterization and Significant Cost Savings ROCHESTER, New York, December 15, 2014 /PRNewswire/ --
DALLAS, December 15, 2014 /PRNewswire/ -- According to the new research report "The Pharmaceutical Excipients Market by Products (Organic chemicals, Inorganic Chemicals),
Strategy will enable CTCA to expand its clinical research capabilities while maintaining the highest standard of human subject protection PRINCETON, N.J., Dec.